We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
-1.07%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$622M
AUM Growth
-$1.43M
Cap. Flow
+$9.58M
Cap. Flow %
1.54%
Top 10 Hldgs %
59.95%
Holding
37
New
4
Increased
15
Reduced
15
Closed
3

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$19.2M
2
HUM icon
Humana
HUM
+$17M
3
BRKR icon
Bruker
BRKR
+$9.4M
4
ELV icon
Elevance Health
ELV
+$9.31M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$5.52M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$9.93M
2
GILD icon
Gilead Sciences
GILD
+$8.79M
3
BIIB icon
Biogen
BIIB
+$8.1M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$7.22M
5
CVS icon
CVS Health
CVS
+$6.62M

Sector Composition

Rank Sector Weight
1 Healthcare 99.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THC icon
26
Tenet Healthcare
THC
$20.1B
$6.79M 1.09%
328,662
+109,978
+50% +$2.53M
CLVS
27
DELISTED
Clovis Oncology, Inc.
CLVS
$6.42M 1.03%
431,425
+51,648
+14% +$933K
ELAN icon
28
Elanco Animal Health
ELAN
$12.4B
$6.25M 1.01%
185,042
-33,952
-16% -$1.1M
MCK icon
29
McKesson
MCK
$98.5B
$5.94M 0.95%
44,175
-5,325
-11% -$664K
PTLA
30
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$5.53M 0.89%
203,925
-50,576
-20% -$1.59M
ALNY icon
31
Alnylam Pharmaceuticals
ALNY
$36.3B
$5.22M 0.84%
+71,900
New +$5.52M
AGIO icon
32
Agios Pharmaceuticals
AGIO
$2.16B
$5.13M 0.83%
102,913
+45,870
+80% +$2.45M
RARE icon
33
Ultragenyx Pharmaceutical
RARE
$2.65B
$5.06M 0.81%
79,653
+13,718
+21% +$873K
SGMO
34
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2.71M 0.44%
251,698
+12,841
+5% +$137K
LXRX icon
35
Lexicon Pharmaceuticals
LXRX
$1.02B
– –
-376,502
Closed -$2.09M
MRK icon
36
Merck
MRK
$324B
– –
-125,081
Closed -$9.93M
RDY icon
37
Dr. Reddy's Laboratories
RDY
$9.82B
– –
-440,380
Closed -$3.57M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q2 2019 Portfolio in Review

As of Q2 2019, Sector Gamma AS held 37 positions worth $622M, down 0.23% from $624M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Sector Gamma AS's Q2 2019 filing shows 4 new, 15 increased, 15 reduced and 3 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 57,635 shares worth $18M. The largest sale was Merck, an estimated $9.93M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 99% a quarter earlier.

  • Sector Gamma AS's largest Q2 2019 buy was Regeneron Pharmaceuticals: 57,635 shares worth $18M.
  • Sector Gamma AS added most to Elevance Health in Q2 2019, an estimated $9.31M increase.
  • Sector Gamma AS's biggest Q2 2019 reduction was Gilead Sciences, cutting an estimated $8.79M.
  • Sector Gamma AS fully exited Merck in Q2 2019, selling an estimated $9.93M.
  • Sector Gamma AS's ten largest holdings make up 60% of its $622M portfolio in Q2 2019.
  • Sector Gamma AS opened 4 new positions and closed 3 in Q2 2019.
  • Sector Gamma AS's portfolio value fell 0.23% quarter-over-quarter to $622M.

Based on Sector Gamma AS's 13F filing for Q2 2019, filed 31 Jul 2019.